COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,050 Articles (22,627 medRxiv, 8,423 bioRxiv)

Most recent first Previous |  Page 620: Articles 6191-6200  | Next

Contact patterns of UK home delivery drivers and their use of protective measures during the COVID-19 pandemic: a cross-sectional study
Bridgen, J. R. E., Wei, H., Whitfield, C. A., Han, Y., Hall, I., Jewell, C., van Tongeren, M. J., Read, J. M.
10.1101/2022.09.09.22279754 — Posted: 2022-09-09
Improved Robustness of SARS-CoV-2 Whole-Genome Sequencing from Wastewater with a Nonselective Virus Concentration Method
Segelhurst, E., Bard, J. E., Pillsbury, A. N., Lamb, N. A., Zhu, C., Pohlman, A., Boccolucci, A., Emerson, J., Marzullo, B. J., Yergeau, D. A., Nowak, N. J., Bradley, I. M., Surtees, J. A., Ye, Y.
10.1101/2022.09.07.22279692 — Posted: 2022-09-09
Parental experiences of the impacts of COVID-19 on the care of young children; qualitative interview findings from the Nairobi Early Childcare in Slums (NECS) Project
Hughes, R. C., Muendo, R., Bhopal, S. S., Onyango, S., Kimani-Murage, E., Kirkwood, B. R., Hill, Z., Kitsao-Wekulo, P.
10.1101/2022.09.09.22279760 — Posted: 2022-09-09
Modeling vaccine allocation and equity implications of COVID-19 containment strategies
Nakamoto, I.
10.1101/2022.09.05.22279623 — Posted: 2022-09-09
Dynamics of SARS-CoV-2 seroassay sensitivity: a systematic review and modeling study
Owusu-Boaitey, N., Russell, T. W., Meyerowitz-Katz, G., Levin, A. T., Herrera-Esposito, D.
10.1101/2022.09.08.22279731 — Posted: 2022-09-09
Serial cross-sectional estimation of vaccine and infection-induced SARS-CoV-2 sero-prevalence in children and adults, British Columbia, Canada: March 2020 to August 2022
Skowronski, D. M., Kaweski, S. E., Irvine, M. A., Kim, S., Chuang, E. S., Sabaiduc, S., Fraser, M., Reyes, R. C., Henry, B., Levett, P. N., Petric, M., Krajden, M., Sekirov, I.
10.1101/2022.09.09.22279751 — Posted: 2022-09-09
Effectiveness of BNT162b2 and CoronaVac against paediatric COVID-19-associated hospitalization and moderate-to-severe disease
Rosa Duque, J. S., Leung, D., Yip, K. M., Lee, D. H. L., So, H.-k., Wong, W. H. S., Lau, Y. L.
10.1101/2022.09.09.22279426 — Posted: 2022-09-09
Knowledge, Attitude and Practice (KAP) study on COVID-19 among the general population of Nepal.
Shrestha, S., Malla, R., Shrestha, S., Singh, P., Sherchand, J. B.
10.1101/2022.09.07.22279527 — Posted: 2022-09-09
Estimating the performance of mass testing strategies for COVID-19: a case study for Costa Rica
Solis, M., Pasquier, C., Nunez-Corrales, S., Madrigal-Redondo, G., Gatica-Arias, A.
10.1101/2022.09.05.22279618 — Posted: 2022-09-09
What is the long-term impact of COVID-19 on the Health-Related Quality of Life of individuals with mild symptoms (or non-hospitalised): A rapid review
Spencer, L. H., Hendry, A., Makanjuola, A., Davies, J., Pisavadia, K., Hughes, D. A., Fitzsimmons, D., Wilkinson, C., Edwards, R. T., Lewis, R., Cooper, A., Edwards, A. G.
10.1101/2022.09.09.22279642 — Posted: 2022-09-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).